627
Views
25
CrossRef citations to date
0
Altmetric
Review Article

Next generation biomarkers for brain injury

, , , , , , , , , & show all
Pages 44-49 | Published online: 23 Sep 2013

References

  • Abraha HD, Butterworth RJ, Bath PM, et al. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:366–70
  • Rothoerl RD, Woertgen C, Holzschuh M, et al. S-100 serum levels after minor and major head injury. J Trauma 1998;45:765–7
  • Raabe A, Seifert V. Fatal secondary increase in serum S-100B protein after severe head injury. Report of three cases. J Neurosurg 1999;91:875–7
  • Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999;47:1126–30
  • Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001;18:491–8
  • Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004;22:102–7
  • Savola O, Pyhtinen J, Leino TK, et al. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 2004;56:1229–4
  • Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303–10
  • Foerch C, Singer OC, Neumann-Haefelin T, et al. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005;62:1130–4
  • Sanchez-Pena P, Pereira AR, Sourour NA, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008;36:2267–73
  • Moritz S, Schmidt C, Bucher M, et al. Neuromonitoring in carotid surgery: are the results obtained in awake patients transferable to patients under sevoflurane/fentanyl anesthesia? J Neurosurg Anesthesiol 2010;22:21–31
  • Kovesdi E, Luckl J, Bukovics P, et al. Up-date on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 2010;152:1–17
  • Risso FM, Sannia A, Gazzolo D. Preterm and term newborn: primary investigations. J Matern Fetal Neonatal Med 2012;25:70–2
  • Hellström-Westas L, Rosén I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 2006;11:503–11
  • Kochanek PM, Berger RP, Bayir H, et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 2008;14:135–41
  • Gazzolo D, Abella R, Frigiola A, et al. Neuromarkers and unconventional biological fluids. J Matern Fetal Neonatal Med 2010;23:66–9
  • Florio P, Abella R, Marinoni E, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47–72
  • Gazzolo D, Abella R, Marinoni E, et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22:57–61
  • Gazzolo D, Di Iorio R, Marinoni E, et al. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002;30:1356–60
  • Gazzolo D, Bruschettini M, Lituania M, et al. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 2001;47:1836–8
  • Gazzolo D, Marinoni E, Di Iorio R, et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004;32:131–6
  • Gazzolo D, Marinoni E, Di Iorio R, et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 2003;157:1163–8
  • Risso FM, Serpero LD, Zimmermann LJ, et al. Perinatal asphyxia: kidney failure does not affect S100B urine concentrations. Clin Chim Acta 2012;18:150–3
  • Cullen VC, Fredenburg RA, Evans C, et al. Development and advanced validation of an optimized method for the quantitation of Aβ42 in human cerebrospinal fluid. AAPS J 2012;14:510–8
  • Koo J, Byun Y. Current status of PET-imaging probes of β-amyloid plaques. Arch Pharm Res 2013 . [Epub ahead of print]
  • Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352–5
  • Mulligan JC, Painter MJ, O’Donoghue PA, et al. Neonatal asphyxia II. Neonatal mortality and long-term sequelae. J Pediatr 1980;96:903–7
  • Low JA, Lindsay BG, Der-rick EJ. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol 1997;177:1391–4
  • Gazzolo D, Michetti F. Perinatal S100B protein assessment in human unconventional biological fluids: a minireview and new perspectives. Cardiovasc Psychiatry Neurol 2010;2010:703563
  • Ferri GL, Probert L, Cocchia D, et al. Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 1986;297:409–10
  • Pham N, Fazio V, Cucullo L, et al. Extracranial sources of S100B do not affect serum levels. PLoS One. 2010;5(9). doi:pii: e12691. 10.1371/journal.pone.0012691. Erratum in: PLoS One. 2010;5(10). doi: 10.1371/annotation/bdcb41f2-a320-4401-a6ab-86e71738597e. PubMed PMID: 20844757; PubMed Central PMCID: PMC2937027
  • Blennow M, Savman K, Ilves P, et al. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 2001;90:1171--5
  • Gazzolo D, Bruschettini M, Corvino V, et al. S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 2001;47:954–6
  • Gazzolo D, Vinesi P, Marinoni E, et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 2000;46:998–1000
  • Gazzolo D, Bruschettini M, Lituania M, et al. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem 2001;47:1132–3
  • Gazzolo D, Michetti F, Bruschettini M, et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 2003;49:967–70
  • Gazzolo D, Lituania M, Bruschettini M, et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005;38:229–33
  • Gazzolo D, Kornacka M, Bruschettini M, et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 2003;4:1215–8
  • Sannia A, Risso FM, Serpero LD, et al. Antenatal glucocorticoid treatment affects preterm infants' S100B urine concentration in a dose-dependent manner. Clin Chim Acta 2010;411:1539–41
  • Gazzolo D, Bruschettini M, Di Iorio R, et al. Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses. Clin Chem 2002;48:647–50
  • Gazzolo D, Florio P, Ciotti S, et al. S100B protein in urine of preterm newborns with ominous outcome. Pediatr Res 2005;58:1170–4
  • Gazzolo D, Frigiola A, Bashir M, et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One 2009;4:e4298
  • Florio P, Gazzolo D, Luisi S, et al. Activin A in brain injury. Adv Clin Chem 2007;43:117–33
  • Florio P, Frigiola A, Battista R, et al. Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010;2:36–42
  • Florio P, Luisi S, Bruschettini M, et al. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50:2386–9
  • Florio P, Luisi S, Moataza B, et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem 2007;53:520–2
  • Florio P, Perrone S, Luisi S, et al. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516–21
  • Sannia A, Zimmermann LJ, Gavilanes AW, et al. Elevated Activin A Urine Levels are Predictors of Intraventricular Hemorrhage in Preterm Newborns. Acta Paediatr 2013. [Epub ahead of print]
  • Luisi S, Calonaci G, Florio P, et al. Identification of activin A and follistatin in human milk. Growth Factors 2002;20:147–50
  • Bellissima V, Ververs TF, Visser GH, Gazzolo D. Selective serotonin reuptake inhibitors in pregnancy. Curr Med Chem 2012;19:4554–61
  • Bellissima V, Visser GH, Ververs TF, et al. Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood. J Matern Fetal Neonatal Med 2011;24:31–4
  • Di Iorio R, Marinoni E, Lituania M, et al. Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem 2004;37:1112–6
  • Di Iorio R, Marinoni E, Letizia C, et al. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am J Obstet Gynecol 2000;182:650–4
  • Gazzolo D, Marinoni E, Giovannini L, et al. Circulating adrenomedullin is increased in preterm newborns developing intraventricular hemorrhage. Pediatr Res 2001;50:544–7
  • Di Iorio R, Marinoni E, Gazzolo D, et al. Maternal nitric oxide supplementation increases adrenomedullin concentrations in growth retarded fetuses. Gynecol Endocrinol 2002;16:187–92
  • Florio P, Abella R, Marinoni E, et al. Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem 2008;54:202–6
  • Pahlman S, Esscher T, Bergvall P, Odelstad L. Purification and characterization of human neuron-specific enolase: radioimmunoassay development. Tumour Biol 1984;5:127–39
  • Basile AM, Fusi C, Conti AA, et al. S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol 2001;45:151–9
  • Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133–8
  • Garcia-Alix A, Cabanas F, Pellicer A, et al. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants. Pediatrics 1994;93:234–40
  • Bracci R, Perrone S, Buonocore G. The timing of neonatal brain damage. Biol Neonate 2006;90:145–55
  • Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. J Matern Fetal Neonatal Med 2012;25:2575–8
  • Perrone S, Tataranno ML, Stazzoni G, et al. Oxidative injury in neonatal erythrocytes. J Matern Fetal Neonatal Med 2012;25:104–8
  • Buonocore G, Perrone S, Longini M, et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003;126:1224–30
  • Gazzolo D, Perrone S, Paffetti P, et al. Non protein bound iron concentrations in amniotic fluid. Clin Biochem 2005;38:674–7
  • Foerch C, Curdt I, Yan B, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006;77:181--4
  • Blennow M, Rosengren L, Jonsson S, et al. Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr 1996;85:485--9
  • Ennen CS, Huisman TA, Savage WJ, et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol 2011;205:251--7
  • Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748–55
  • Bainbridge SA, Smith GN. HO in pregnancy. Free Radic Biol Med 2005;38:979–88
  • Denschlag D, Marculescu R, Unfried G, et al. The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 2004;10:211–4
  • Shrestha Dangol D, Chen HP. Role of hemeoxygenase-2 in pregnancy-induced hypertension. Int J Gynaecol Obstet 2004;85: 44–6
  • Eide IP, Isaksen CV, Salvesen KA, et al. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Acta Obstet Gynecol Scand 2008;87:272–9
  • Barber A, Robson SC, Myatt L, et al. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J 2001;15:1158–68
  • Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol 2007;71:817–25
  • Fujita T, Toda K, Karimova A, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by de-repression of fibrinolysis. Nat Med 2001;7:598–604
  • Li Volti G, Galvano F, Frigiola A, et al. Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach. J Nutr Biochem 2010;21:865–71
  • Sannia A, Zimmermann LJ, Gavilanes AW, et al. S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 2011;412:1337–40
  • Sannia A, Risso FM, Zimmermann LJ, et al. S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta 2013;417:31–4
  • Gazzolo D, Frulio R, Roletti A, et al. S100A1B and S100BB urine levels in preterm and term healthy newborns. Clin Chim Acta 2007;384:186–7
  • Florio P, Marinoni E, Di Iorio R, et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics 2006;118:e747–54
  • Risso FM, Serpero LD, Zimmermann LJ, et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr 2013. [Epub ahead of print]
  • Florio P, Michetti F, Bruschettini M, et al. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 2004;364:270–2
  • Michetti F, Corvino V, Geloso MC, et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644–59
  • Risso FM, Sannia A, Gavilanes DA, et al. Biomarkers of brain damage in preterm infants. J Matern Fetal Neonatal Med 2012;25:101–4
  • Gazzolo D, Serpero LD, Frigiola A, et al. Antenatal glucocorticoids supplementation and central nervous system development. Curr Drug Metab 2013;14:160–6
  • Atzori L, Antonucci R, Barberini L, et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011;3:1005–12
  • Dessì A, Atzori L, Noto A, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011;24:35–9
  • Roka A, Kelen D, Halasz J, et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr 2012;101:319–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.